Kepler Capital Markets Boosts Benchmark (BMK) Price Target to GBX 77

Benchmark (LON:BMK) had its price objective hoisted by investment analysts at Kepler Capital Markets from GBX 68 ($0.92) to GBX 77 ($1.04) in a research report issued on Thursday. The brokerage currently has a “buy” rating on the stock. Kepler Capital Markets’ target price points to a potential upside of 14.93% from the stock’s current price.

A number of other brokerages also recently issued reports on BMK. Beaufort Securities assumed coverage on Benchmark in a report on Wednesday. They issued a “speculative buy” rating and a GBX 80 ($1.08) price target on the stock. Numis Securities reiterated an “add” rating and issued a GBX 78 ($1.06) price target on shares of Benchmark in a report on Tuesday.

Shares of Benchmark (BMK) traded down GBX 2 ($0.03) during trading hours on Thursday, hitting GBX 67 ($0.91). The stock had a trading volume of 413,464 shares, compared to its average volume of 356,563. Benchmark has a twelve month low of GBX 36.50 ($0.49) and a twelve month high of GBX 111.50 ($1.51). The stock has a market cap of $347.97 and a P/E ratio of -6,700.00.

In related news, insider Kevin Quinn purchased 35,929 shares of the business’s stock in a transaction dated Tuesday, January 23rd. The shares were acquired at an average cost of GBX 70 ($0.95) per share, for a total transaction of £25,150.30 ($34,106.73).

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/27/kepler-capital-markets-boosts-benchmark-bmk-price-target-to-gbx-77.html.

About Benchmark

Benchmark Holdings plc is engaged in the provision of technical services, products and specialist knowledge that support the global development of sustainable food and farming industries. The Company’s segments include Animal Health Division, which provides veterinary services, environmental services diagnostics and animal health products to global aquaculture, and manufactures licensed veterinary vaccines and vaccine components; Breeding and Genetics Division, which provides a range of year-round high genetic merit ova; Advanced Animal Nutrition, which manufactures and provides nutrition and health products to the global aquaculture industry; Sustainability Science Division, which provides sustainable food production consultancy, technical consultancy and assurance services; Technical Publishing Division, which promotes sustainable food production and ethics through online news and technical publications, and through delivery of training courses to the industries, and Corporate.

Receive News & Ratings for Benchmark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Benchmark and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply